Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The study aims to ascertain whether the sole replacement of tenofovir with abacavir once a
day improves the immunological response obtained with tenofovir + ddI or whether it is better
to perform a double replacement of tenofovir and ddI with abacavir + lamivudine (joint
formulation) in a single daily dose to achieve these objectives.